These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 35628462)
1. Association between Decreased ITGA7 Levels and Increased Muscle α-Synuclein in an MPTP-Induced Mouse Model of Parkinson's Disease. Han S; Lim S; Yeo S Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628462 [TBL] [Abstract][Full Text] [Related]
2. Decrease in Han S; Seo MH; Lim S; Yeo S Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422 [TBL] [Abstract][Full Text] [Related]
3. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model. Seo MH; Yeo S Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636 [TBL] [Abstract][Full Text] [Related]
4. Association between SGK1 and α-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model. Heo EJ; Lee Y; Hyung Seo M; Yeo S Neurosci Lett; 2023 Sep; 814():137464. PubMed ID: 37634811 [TBL] [Abstract][Full Text] [Related]
5. Seo MH; Yeo S Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502283 [TBL] [Abstract][Full Text] [Related]
6. Acupuncture Inhibits the Increase in Alpha-Synuclein in Substantia Nigra in an MPTP- Induced Parkinsonism Mouse Model. Yeo S; Song J; Lim S Adv Exp Med Biol; 2020; 1232():401-408. PubMed ID: 31893437 [TBL] [Abstract][Full Text] [Related]
7. Naringenin Decreases α-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson's Disease Model in Mice. Mani S; Sekar S; Barathidasan R; Manivasagam T; Thenmozhi AJ; Sevanan M; Chidambaram SB; Essa MM; Guillemin GJ; Sakharkar MK Neurotox Res; 2018 Apr; 33(3):656-670. PubMed ID: 29427283 [TBL] [Abstract][Full Text] [Related]
8. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein. Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells. Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467 [TBL] [Abstract][Full Text] [Related]
10. The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease. Mariucci G; Pagiotti R; Galli F; Romani L; Conte C J Mol Neurosci; 2018 Apr; 64(4):611-618. PubMed ID: 29589201 [TBL] [Abstract][Full Text] [Related]
11. Acupuncture Inhibits the Increase in Alpha-Synuclein by Modulating SGK1 in an MPTP Induced Parkinsonism Mouse Model. Yeo S; Lim S Am J Chin Med; 2019; 47(3):527-539. PubMed ID: 30966771 [TBL] [Abstract][Full Text] [Related]
12. [Neuroprotective effect of cinnamaldehyde in MPTP-induced mouse model of subacute Parkinson's disease]. Wu SH; Shi YJ; An YF; Zhao DD; Li HB; Li GL Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(23):6485-6493. PubMed ID: 36604895 [TBL] [Abstract][Full Text] [Related]
13. 7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing α-synuclein Expression and Oxidative Stress in the MPTP-induced Mouse Model of Parkinson's Disease. Li XH; Dai CF; Chen L; Zhou WT; Han HL; Dong ZF CNS Neurosci Ther; 2016 Jul; 22(7):617-24. PubMed ID: 27079181 [TBL] [Abstract][Full Text] [Related]
14. α-Synuclein Expression Is Preserved in Substantia Nigra GABAergic Fibers of Young and Aged Neurotoxin-Treated Rhesus Monkeys. Vermilyea SC; Guthrie S; Hernandez I; Bondarenko V; Emborg ME Cell Transplant; 2019 Apr; 28(4):379-387. PubMed ID: 30857404 [TBL] [Abstract][Full Text] [Related]
15. The Involvement of Progranulin for α-Synuclein Reduction through Autolysosome Formation. Fujimori H; Ohba T; Nakamura S; Shimazawa M; Hara H Biol Pharm Bull; 2023; 46(8):1032-1040. PubMed ID: 37532554 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylated α-Synuclein Accumulations and Lewy Body-like Pathology Distributed in Parkinson's Disease-Related Brain Areas of Aged Rhesus Monkeys Treated with MPTP. Huang B; Wu S; Wang Z; Ge L; Rizak JD; Wu J; Li J; Xu L; Lv L; Yin Y; Hu X; Li H Neuroscience; 2018 May; 379():302-315. PubMed ID: 29592843 [TBL] [Abstract][Full Text] [Related]
17. Treadmill exercise alleviates motor deficits and improves mitochondrial import machinery in an MPTP-induced mouse model of Parkinson's disease. Koo JH; Cho JY; Lee UB Exp Gerontol; 2017 Mar; 89():20-29. PubMed ID: 28062370 [TBL] [Abstract][Full Text] [Related]
18. Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson's Disease. Duperrier S; Bortolozzi A; Sgambato V Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955716 [TBL] [Abstract][Full Text] [Related]
19. Analysis of m6A modification regulators in the substantia nigra and striatum of MPTP-induced Parkinson's disease mice. Yu Z; Huang L; Xia Y; Cheng S; Yang C; Chen C; Zou Z; Wang X; Tian X; Jiang X; Zhou L Neurosci Lett; 2022 Nov; 791():136907. PubMed ID: 36209975 [TBL] [Abstract][Full Text] [Related]
20. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice. Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]